Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA

BACKGROUND: The intravitreal anti-vascular endothelial growth factor treatments ranibizumab and aflibercept have proven efficacy in clinical trials, but their real world usage in central retinal vein occlusion (CRVO) has not been assessed. We therefore evaluated the treatment patterns of both drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotery, A J, Regnier, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366471/
https://www.ncbi.nlm.nih.gov/pubmed/25572584
http://dx.doi.org/10.1038/eye.2014.308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366471/
https://www.ncbi.nlm.nih.gov/pubmed/25572584
http://dx.doi.org/10.1038/eye.2014.308

Ejemplares similares